feed,title,long_url,short_url
Benzinga,FDA Advisory Committee Backs Bluebird Bio's Blood Disorder Gene Therapy,https://benzinga.com/general/biotech/22/06/27666144/fda-adcomm-backs-bluebird-bios-blood-disorder-gene-therapy,https://bit.ly/3aRpSMB
Benzinga,Sanofi-GSK's Next-Gen COVID-19 Booster Shows Potential Against Variants Of Concern,https://benzinga.com/general/biotech/22/06/27666003/sanofi-gsks-next-gen-covid-19-booster-shows-potential-against-variants-of-concern,https://bit.ly/3MPxhJA
